Study details
Enrolling now
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Aptitude Medical Systems
NCT IDNCT06744660ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,000
Study length
about 1.1 years
Ages
2+
Locations
3 sites in AL, LA
About this study
Researchers are testing a test to detect COVID-19. The test will be used in home settings, and it's being evaluated for accuracy compared to an FDA-cleared assay. The trial will take place at multiple sites across the United States.
Based on ClinicalTrials.gov records.
What participants do
- 1.Aptitude Medical Systems Metrix COVID Test
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
diagnostic
Body systems
Infectious